# Hypofractionation for Prostate Cancer in Africa: A Feasibility Study

> **NCT06950307** · — · ACTIVE_NOT_RECRUITING · sponsor: **Muhimbili University of Health and Allied Sciences** · enrollment: 182 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Hypofractionated radiotherapy for low- and intermediate-risk prostate cancer patients
- **RADIATION:** Hypofractionated radiotherapy for high-risk prostate cancer patients

## Key facts

- **NCT ID:** NCT06950307
- **Lead sponsor:** Muhimbili University of Health and Allied Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-30
- **Primary completion:** 2026-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06950307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06950307, "Hypofractionation for Prostate Cancer in Africa: A Feasibility Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06950307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*